DDrare
Disease
Drug
Target Gene/Pathway
Contact
JA
Target Gene/Pathway
Pathway
/
Gene
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
entries per page:
Showing 1 to 10 of 26 entries
Filter by
Reset
No.
KEGG GENES
KEGG PATHWAY
KEGG DRUG
DrugBank
Disease ID
1
IL1B
[24]
MAPK signaling pathway
MAPK signaling pathway
,
NF-kappa B signaling pathway
,
Necroptosis
,
Osteoclast differentiation
,
Toll-like receptor signaling pathway
,
NOD-like receptor signaling pathway
,
Th17 cell differentiation
,
TNF signaling pathway
,
Non-alcoholic fatty liver disease
,
Type I diabetes mellitus
,
Prion disease
,
Pathways of neurodegeneration - multiple diseases
,
Pathogenic Escherichia coli infection
,
Shigellosis
,
Salmonella infection
,
Pertussis
,
Legionellosis
,
Yersinia infection
,
Leishmaniasis
,
Malaria
,
Tuberculosis
,
Measles
,
Rheumatoid arthritis
,
Lipid and atherosclerosis
[24]
MAPK signaling pathway
,
NF-kappa B signaling pathway
,
Necroptosis
,
Osteoclast differentiation
, ...
D01583
D01583
Pirfenidone
[11]
13
13
,
34
,
46
,
50
,
51
,
58
,
84
,
85
,
164
,
222
,
228
2
IL1B
[24]
MAPK signaling pathway
MAPK signaling pathway
,
NF-kappa B signaling pathway
,
Necroptosis
,
Osteoclast differentiation
,
Toll-like receptor signaling pathway
,
NOD-like receptor signaling pathway
,
Th17 cell differentiation
,
TNF signaling pathway
,
Non-alcoholic fatty liver disease
,
Type I diabetes mellitus
,
Prion disease
,
Pathways of neurodegeneration - multiple diseases
,
Pathogenic Escherichia coli infection
,
Shigellosis
,
Salmonella infection
,
Pertussis
,
Legionellosis
,
Yersinia infection
,
Leishmaniasis
,
Malaria
,
Tuberculosis
,
Measles
,
Rheumatoid arthritis
,
Lipid and atherosclerosis
[24]
MAPK signaling pathway
,
NF-kappa B signaling pathway
,
Necroptosis
,
Osteoclast differentiation
, ...
D06635
D06635
Rilonacept
[4]
51
51
,
106
,
107
,
266
3
IL1B
[24]
MAPK signaling pathway
MAPK signaling pathway
,
NF-kappa B signaling pathway
,
Necroptosis
,
Osteoclast differentiation
,
Toll-like receptor signaling pathway
,
NOD-like receptor signaling pathway
,
Th17 cell differentiation
,
TNF signaling pathway
,
Non-alcoholic fatty liver disease
,
Type I diabetes mellitus
,
Prion disease
,
Pathways of neurodegeneration - multiple diseases
,
Pathogenic Escherichia coli infection
,
Shigellosis
,
Salmonella infection
,
Pertussis
,
Legionellosis
,
Yersinia infection
,
Leishmaniasis
,
Malaria
,
Tuberculosis
,
Measles
,
Rheumatoid arthritis
,
Lipid and atherosclerosis
[24]
MAPK signaling pathway
,
NF-kappa B signaling pathway
,
Necroptosis
,
Osteoclast differentiation
, ...
D09315
D09315
Canakinumab
[10]
46
46
,
56
,
84
,
106
,
107
,
108
,
113
,
266
,
267
,
269
4
IL1B
[24]
MAPK signaling pathway
MAPK signaling pathway
,
NF-kappa B signaling pathway
,
Necroptosis
,
Osteoclast differentiation
,
Toll-like receptor signaling pathway
,
NOD-like receptor signaling pathway
,
Th17 cell differentiation
,
TNF signaling pathway
,
Non-alcoholic fatty liver disease
,
Type I diabetes mellitus
,
Prion disease
,
Pathways of neurodegeneration - multiple diseases
,
Pathogenic Escherichia coli infection
,
Shigellosis
,
Salmonella infection
,
Pertussis
,
Legionellosis
,
Yersinia infection
,
Leishmaniasis
,
Malaria
,
Tuberculosis
,
Measles
,
Rheumatoid arthritis
,
Lipid and atherosclerosis
[24]
MAPK signaling pathway
,
NF-kappa B signaling pathway
,
Necroptosis
,
Osteoclast differentiation
, ...
D09911
D09911
Gevokizumab
[4]
41
41
,
50
,
56
,
269
5
IL6
[21]
Viral protein interaction with cytokine and cytokine receptor
Viral protein interaction with cytokine and cytokine receptor
,
PI3K-Akt signaling pathway
,
Toll-like receptor signaling pathway
,
NOD-like receptor signaling pathway
,
Th17 cell differentiation
,
TNF signaling pathway
,
Non-alcoholic fatty liver disease
,
Prion disease
,
Pathways of neurodegeneration - multiple diseases
,
Pathogenic Escherichia coli infection
,
Salmonella infection
,
Pertussis
,
Legionellosis
,
Yersinia infection
,
Malaria
,
Tuberculosis
,
Measles
,
Pathways in cancer
,
Transcriptional misregulation in cancer
,
Rheumatoid arthritis
,
Lipid and atherosclerosis
[21]
Viral protein interaction with cytokine and cytokine receptor
,
PI3K-Akt signaling pathway
,
Toll
...
D01583
D01583
Pirfenidone
[11]
13
13
,
34
,
46
,
50
,
51
,
58
,
84
,
85
,
164
,
222
,
228
6
IL6
[21]
Viral protein interaction with cytokine and cytokine receptor
Viral protein interaction with cytokine and cytokine receptor
,
PI3K-Akt signaling pathway
,
Toll-like receptor signaling pathway
,
NOD-like receptor signaling pathway
,
Th17 cell differentiation
,
TNF signaling pathway
,
Non-alcoholic fatty liver disease
,
Prion disease
,
Pathways of neurodegeneration - multiple diseases
,
Pathogenic Escherichia coli infection
,
Salmonella infection
,
Pertussis
,
Legionellosis
,
Yersinia infection
,
Malaria
,
Tuberculosis
,
Measles
,
Pathways in cancer
,
Transcriptional misregulation in cancer
,
Rheumatoid arthritis
,
Lipid and atherosclerosis
[21]
Viral protein interaction with cytokine and cytokine receptor
,
PI3K-Akt signaling pathway
,
Toll
...
D08976
D08976
Pomalidomide
[5]
28
28
,
51
,
85
,
227
,
331
7
IL6
[21]
Viral protein interaction with cytokine and cytokine receptor
Viral protein interaction with cytokine and cytokine receptor
,
PI3K-Akt signaling pathway
,
Toll-like receptor signaling pathway
,
NOD-like receptor signaling pathway
,
Th17 cell differentiation
,
TNF signaling pathway
,
Non-alcoholic fatty liver disease
,
Prion disease
,
Pathways of neurodegeneration - multiple diseases
,
Pathogenic Escherichia coli infection
,
Salmonella infection
,
Pertussis
,
Legionellosis
,
Yersinia infection
,
Malaria
,
Tuberculosis
,
Measles
,
Pathways in cancer
,
Transcriptional misregulation in cancer
,
Rheumatoid arthritis
,
Lipid and atherosclerosis
[21]
Viral protein interaction with cytokine and cytokine receptor
,
PI3K-Akt signaling pathway
,
Toll
...
D09669
D09669
Siltuximab
[2]
28
28
,
331
8
IL6
[21]
Viral protein interaction with cytokine and cytokine receptor
Viral protein interaction with cytokine and cytokine receptor
,
PI3K-Akt signaling pathway
,
Toll-like receptor signaling pathway
,
NOD-like receptor signaling pathway
,
Th17 cell differentiation
,
TNF signaling pathway
,
Non-alcoholic fatty liver disease
,
Prion disease
,
Pathways of neurodegeneration - multiple diseases
,
Pathogenic Escherichia coli infection
,
Salmonella infection
,
Pertussis
,
Legionellosis
,
Yersinia infection
,
Malaria
,
Tuberculosis
,
Measles
,
Pathways in cancer
,
Transcriptional misregulation in cancer
,
Rheumatoid arthritis
,
Lipid and atherosclerosis
[21]
Viral protein interaction with cytokine and cytokine receptor
,
PI3K-Akt signaling pathway
,
Toll
...
D10080
D10080
Sirukumab
[2]
41
41
,
46
9
IL6
[21]
Viral protein interaction with cytokine and cytokine receptor
Viral protein interaction with cytokine and cytokine receptor
,
PI3K-Akt signaling pathway
,
Toll-like receptor signaling pathway
,
NOD-like receptor signaling pathway
,
Th17 cell differentiation
,
TNF signaling pathway
,
Non-alcoholic fatty liver disease
,
Prion disease
,
Pathways of neurodegeneration - multiple diseases
,
Pathogenic Escherichia coli infection
,
Salmonella infection
,
Pertussis
,
Legionellosis
,
Yersinia infection
,
Malaria
,
Tuberculosis
,
Measles
,
Pathways in cancer
,
Transcriptional misregulation in cancer
,
Rheumatoid arthritis
,
Lipid and atherosclerosis
[21]
Viral protein interaction with cytokine and cytokine receptor
,
PI3K-Akt signaling pathway
,
Toll
...
D12487
D12487
Olokizumab
[2]
46
46
,
96
10
IL12A
[13]
Toll-like receptor signaling pathway
Toll-like receptor signaling pathway
,
RIG-I-like receptor signaling pathway
,
Th1 and Th2 cell differentiation
,
Type I diabetes mellitus
,
Pertussis
,
Legionellosis
,
Leishmaniasis
,
Malaria
,
Toxoplasmosis
,
Tuberculosis
,
Measles
,
Pathways in cancer
,
Lipid and atherosclerosis
[13]
Toll-like receptor signaling pathway
,
RIG-I-like receptor signaling pathway
,
Th1 and Th2 cell d
...
D09214
D09214
Ustekinumab
[16]
37
37
,
40
,
41
,
46
,
49
,
50
,
56
,
65
,
84
,
93
,
96
,
97
,
160
,
162
,
269
,
271